GSK PLC 2024 SR
The report details GSK's 2024 performance across six responsible business focus areas: access, global health, environment, inclusion and diversity, ethical standards, and product governance. Key highlights include reaching over 2 billion people with products since 2021 and reducing operational carbon emissions by 36% against a 2020 baseline. The company progressed six global health pipeline assets and achieved an 88% representation rate in phase III clinical trials. GSK also maintained its "on track" Responsible Business Performance Rating for the third consecutive year.
Company: GSK PLC
Sector: Health Care
Country: United Kingdom
Year: 2024
Type: SR
Pages: 54
GSK PLC
Responsible Business Performance Report
The report details GSK's 2024 performance across six responsible business focus areas: access, global health, environment, inclusion and diversity, ethical standards, and product governance. Key highlights include reaching over 2 billion people with products since 2021 and reducing operational carbon emissions by 36% against a 2020 baseline. The company progressed six global health pipeline assets and achieved an 88% representation rate in phase III clinical trials. GSK also maintained its "on track" Responsible Business Performance Rating for the third consecutive year.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Feb 27, 2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women in Management
Workplace Fatalities
Net Zero Target